Subcommittee for Dose Reconstruction Reviews (SDRR), Advisory Board on Radiation and Worker Health (ABRWH or the Advisory Board), National Institute for Occupational Safety and Health (NIOSH), 65554-65555 [2012-26495]
Download as PDF
<![CDATA[
65554
Federal Register / Vol. 77, No. 209 / Monday, October 29, 2012 / Notices
extent to which the targeted populations
have been reached; (2) Document how
well the project is progressing in
meeting goals/objectives set forth by
CDC (e.g. who delivered what to whom,
how many, where, when, and how
well), as well as performance indicators
related to testing, counseling and
linkage to care; (3) Highlight
opportunities for local program
collaboration and service integration
(PCSI) to prevent hepatitis: (4)Fulfill
data collection and reporting
requirements outlined in the
cooperative agreements.
The data will enable CDC to be
accountable for the funding it provides,
the populations that are served, the
services being provided, and for the
strategies and practices effectiveness in
implementing HEPTLC. The data will
also enable CDC to be accountable to the
administration, Congress, or other
stakeholders for the proper use of public
money or provide transparency for the
programs it funds.
Respondents will be testing sites at
multiple settings, including health
departments, community based
organizations (CBOs), community health
centers (CHCs), person who inject drugs
(PWID) treatment centers, and other
settings, e.g. HIV or STD clinics,
Federally Qualified Health Centers
(FQHCs). They will routinely collect,
enter, and report information about the
test site, client demographics and
behaviors, testing results and linkage to
care follow up information within the
web-based HEPTLC system. CDC
anticipates that routine information
collection will begin once OMB
approval is received and will be carried
out through the project period
September 2012–September 2013.
There are no costs to respondents
other than their time. The total
estimated annual burden hours are
6000.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Average
burden per
response
(in hours)
Responses
per
respondent
Type of respondents
Form name
HBV—CBOs/Health Jurisdictions ..................
HCV—multiple sites (IDU, CHCs, Others,
ECHO)
HBV—CBOs/Health Jurisdictions ..................
HCV—multiple sites (IDU, CHCs, Others,
ECHO)
HEPTLC Data Variables & Values (test-level
monthly reporting).
40
12
HEPTLC Template (program-level reporting/
quarterly).
40
4
Dated: October 22, 2012.
Ron A. Otten,
Director, Office of Scientific Integrity (OSI),
Office of the Associate Director for Science
(OADS), Office of the Director, Centers for
Disease Control and Prevention.
[FR Doc. 2012–26498 Filed 10–26–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Subcommittee for Dose
Reconstruction Reviews (SDRR),
Advisory Board on Radiation and
Worker Health (ABRWH or the
Advisory Board), National Institute for
Occupational Safety and Health
(NIOSH)
rmajette on DSK2TPTVN1PROD with
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting for the
aforementioned subcommittee:
Time and Date: 8:30 a.m.–5:00 p.m.
Eastern Time, November 27, 2012.
Place: Cincinnati Airport Marriott, 2395
Progress Drive, Hebron, Kentucky 41018.
Telephone (859) 334–4611, Fax (859) 334–
4619.
Status: Open to the public, but without an
oral public comment period. To access by
VerDate Mar<15>2010
13:18 Oct 26, 2012
Jkt 229001
conference call dial the following
information 1 (866) 659–0537, Participant
Pass Code 9933701.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation Program
Act of 2000 to advise the President on a
variety of policy and technical functions
required to implement and effectively
manage the new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines that have
been promulgated by the Department of
Health and Human Services (HHS) as a final
rule; advice on methods of dose
reconstruction, which have also been
promulgated by HHS as a final rule; advice
on the scientific validity and quality of dose
estimation and reconstruction efforts being
performed for purposes of the compensation
program; and advice on petitions to add
classes of workers to the Special Exposure
Cohort (SEC).
In December 2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS, which
subsequently delegated this authority to CDC.
NIOSH implements this responsibility for
CDC. The charter was issued on August 3,
2001, renewed at appropriate intervals, and
will expire on August 3, 2013.
Purpose: The Advisory Board is charged
with (a) providing advice to the Secretary,
HHS, on the development of guidelines
under Executive Order 13179; (b) providing
advice to the Secretary, HHS, on the
scientific validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advise the Secretary on
PO 00000
Frm 00024
Fmt 4703
Sfmt 4703
12
1.5
whether there is a class of employees at any
Department of Energy facility who were
exposed to radiation but for whom it is not
feasible to estimate their radiation dose, and
on whether there is reasonable likelihood
that such radiation doses may have
endangered the health of members of this
class. The Subcommittee for Dose
Reconstruction Reviews was established to
aid the Advisory Board in carrying out its
duty to advise the Secretary, HHS, on dose
reconstruction.
Matters To Be Discussed: The agenda for
the Subcommittee meeting includes:
Reconsidering the Board’s dose
reconstruction case review process; dose
reconstruction program quality management
and assurance activities, including: Current
findings from NIOSH internal dose
reconstruction blind reviews, presentation of
the test plan for validating dose
reconstruction tools, presentation of the
evolution of peer-review procedures,
presentation of statistics summarizing errors
detected and/or corrected through current
peer-review procedures; and discussion of
dose reconstruction cases under review (sets
8–9, Rocky Flats Plant cases from sets 10–13,
and two blind dose reconstruction cases).
The agenda is subject to change as
priorities dictate.
In the event an individual cannot attend,
written comments may be submitted. Any
written comments received will be provided
at the meeting and should be submitted to
the contact person below well in advance of
the meeting.
Contact Person for More Information:
Theodore Katz, Executive Secretary, NIOSH,
CDC, 1600 Clifton Road, Mailstop E–20,
Atlanta, Georgia 30333. Telephone (513)
E:\FR\FM\29OCN1.SGM
29OCN1
Federal Register / Vol. 77, No. 209 / Monday, October 29, 2012 / Notices
533–6800, Toll Free 1 (800) CDC–INFO,
Email ocas@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: October 22, 2012.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention (CDC).
[FR Doc. 2012–26490 Filed 10–26–12; 8:45 am]
Dated: October 22, 2012.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
BILLING CODE 4163–18–P
[FR Doc. 2012–26495 Filed 10–26–12; 8:45 am]
Food and Drug Administration
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4163–18–P
[Docket No. FDA–2012–N–0547]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Council for the Elimination of
Tuberculosis (ACET)
rmajette on DSK2TPTVN1PROD with
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Times and Dates: 8:30 a.m.–5:30 p.m.,
December 4, 2012; 8:30 a.m.–2:30 p.m.,
December 5, 2012.
Place: CDC, Corporate Square, 1800
Corporate Boulevard, Building 8, 1st Floor
Conference Room, Atlanta, Georgia 30329,
Telephone: (404) 639–8317.
Status: Open to the public, limited only by
the space available. The meeting room
accommodates approximately 100 people.
Purpose: This council advises and makes
recommendations to the Secretary of Health
and Human Services, the Assistant Secretary
for Health, and the Director, CDC, regarding
the elimination of tuberculosis. Specifically,
the Council makes recommendations
regarding policies, strategies, objectives, and
priorities; addresses the development and
application of new technologies; and reviews
the extent to which progress has been made
toward eliminating tuberculosis.
Matters To Be Discussed: Agenda items
include the following topics: (1) CDC’s efforts
on global tuberculosis control; (2) The
epidemiology of TB–HIV in the United
States; (3) Post-deployment tuberculosis in
the United States military; (4) ACET
workgroups activities updates; and (5) other
tuberculosis-related issues.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Margie Scott-Cseh, CDC, 1600 Clifton Road
NE., M/S E–07, Atlanta, Georgia 30333,
Telephone: (404) 639–8317.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register Notices
pertaining to announcements of meetings and
other committee management activities, for
VerDate Mar<15>2010
13:18 Oct 26, 2012
Jkt 229001
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Survey on the
Occurrence of Foodborne Illness Risk
Factors in Selected Retail and
Foodservice Facility Types (2013–
2022)
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995
(the PRA).
DATES: Fax written comments on the
collection of information by November
28, 2012.
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–7285, or emailed to
oira_submission@omb.eop.gov. All
comments should be identified with the
OMB control number 0910–NEW and
title ‘‘Survey on the Occurrence of
Foodborne Illness Risk Factors in
Selected Retail and Foodservice Facility
Types (2013–2022).’’ Also include the
FDA docket number found in brackets
in the heading of this document.
FOR FURTHER INFORMATION CONTACT: Ila
S. Mizrachi, Office of Information
Management, Food and Drug
Administration, 1350 Piccard Dr., PI50–
400B, Rockville, MD 20850, 301–796–
7726, Ila.Mizrachi@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
SUMMARY:
PO 00000
Frm 00025
Fmt 4703
Sfmt 4703
65555
Survey on the Occurrence of Foodborne
Illness Risk Factors in Selected Retail
and Foodservice Facility Types (2013–
2022)—(OMB Control Number 0910–
NEW)
I. Background
In 1998, the U.S. Food and Drug
Administration’s National Retail Food
Team initiated a 10-year voluntary
survey to measure trends in the
occurrence of foodborne illness risk
factors—preparation practices and
employee behaviors most commonly
reported to the Centers for Disease
Control and Prevention (CDC) as
contributing factors to foodborne illness
outbreaks at the retail level.
Specifically, the survey included data
collection inspections of various types
of retail and foodservice establishments
at 5-year intervals (1998, 2003, and
2008) in order to observe and document
trends in the occurrence of the
following foodborne illness risk factors:
• Food from Unsafe Sources.
• Poor Personal Hygiene.
• Inadequate Cooking.
• Improper Holding/Time and
Temperature.
• Contaminated Equipment/
Protection from Contamination.
FDA developed reports summarizing
the findings for each of the three data
collection periods (1998, 2003, and
2008) (Refs. 1 to 3). Data from all three
data collection periods were analyzed to
detect trends in improvement or
regression over time and to determine
whether progress had been made toward
the goal of reducing the occurrence of
foodborne illness risk factors in selected
retail and foodservice facility types (Ref.
4).
The research obtained from these
studies provides FDA a solid foundation
for developing a national retail food
program model that can be used by
Federal, State, local, and tribal agencies
to:
• Identify essential food safety
program performance measurements;
• Assess strengths and gaps in the
design, structure, and delivery of
program services;
• Establish program priorities and
intervention strategies focused on
reducing the occurrence of foodborne
illness risk factors; and
• Create a mechanism that justifies
program resources and allocates them to
program areas that will provide the most
significant public health benefits.
Using this 10-year survey as a
foundation, FDA is proposing to
conduct a new voluntary survey
encompassing annual data collections
over a 10-year period. The survey will
E:\FR\FM\29OCN1.SGM
29OCN1
]]>Agencies
[Federal Register Volume 77, Number 209 (Monday, October 29, 2012)]
[Notices]
[Pages 65554-65555]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-26495]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Subcommittee for Dose Reconstruction Reviews (SDRR), Advisory
Board on Radiation and Worker Health (ABRWH or the Advisory Board),
National Institute for Occupational Safety and Health (NIOSH)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), announces the following meeting for the
aforementioned subcommittee:
Time and Date: 8:30 a.m.-5:00 p.m. Eastern Time, November 27,
2012.
Place: Cincinnati Airport Marriott, 2395 Progress Drive, Hebron,
Kentucky 41018. Telephone (859) 334-4611, Fax (859) 334-4619.
Status: Open to the public, but without an oral public comment
period. To access by conference call dial the following information
1 (866) 659-0537, Participant Pass Code 9933701.
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program Act of 2000 to
advise the President on a variety of policy and technical functions
required to implement and effectively manage the new compensation
program. Key functions of the Advisory Board include providing
advice on the development of probability of causation guidelines
that have been promulgated by the Department of Health and Human
Services (HHS) as a final rule; advice on methods of dose
reconstruction, which have also been promulgated by HHS as a final
rule; advice on the scientific validity and quality of dose
estimation and reconstruction efforts being performed for purposes
of the compensation program; and advice on petitions to add classes
of workers to the Special Exposure Cohort (SEC).
In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to CDC. NIOSH implements this
responsibility for CDC. The charter was issued on August 3, 2001,
renewed at appropriate intervals, and will expire on August 3, 2013.
Purpose: The Advisory Board is charged with (a) providing advice
to the Secretary, HHS, on the development of guidelines under
Executive Order 13179; (b) providing advice to the Secretary, HHS,
on the scientific validity and quality of dose reconstruction
efforts performed for this program; and (c) upon request by the
Secretary, HHS, advise the Secretary on whether there is a class of
employees at any Department of Energy facility who were exposed to
radiation but for whom it is not feasible to estimate their
radiation dose, and on whether there is reasonable likelihood that
such radiation doses may have endangered the health of members of
this class. The Subcommittee for Dose Reconstruction Reviews was
established to aid the Advisory Board in carrying out its duty to
advise the Secretary, HHS, on dose reconstruction.
Matters To Be Discussed: The agenda for the Subcommittee meeting
includes: Reconsidering the Board's dose reconstruction case review
process; dose reconstruction program quality management and
assurance activities, including: Current findings from NIOSH
internal dose reconstruction blind reviews, presentation of the test
plan for validating dose reconstruction tools, presentation of the
evolution of peer-review procedures, presentation of statistics
summarizing errors detected and/or corrected through current peer-
review procedures; and discussion of dose reconstruction cases under
review (sets 8-9, Rocky Flats Plant cases from sets 10-13, and two
blind dose reconstruction cases).
The agenda is subject to change as priorities dictate.
In the event an individual cannot attend, written comments may
be submitted. Any written comments received will be provided at the
meeting and should be submitted to the contact person below well in
advance of the meeting.
Contact Person for More Information: Theodore Katz, Executive
Secretary, NIOSH, CDC, 1600 Clifton Road, Mailstop E-20, Atlanta,
Georgia 30333. Telephone (513)
[[Page 65555]]
533-6800, Toll Free 1 (800) CDC-INFO, Email ocas@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Dated: October 22, 2012.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2012-26495 Filed 10-26-12; 8:45 am]
BILLING CODE 4163-18-P
